Latest News

Mycardium AI Limited is committed to Data Security and Privacy, has successfully passed both Stage 1 and Stage 2 of its ISO 27001 audit and is awaiting the formal award of its certificate. The ISO 27001 certification is an internationally recognized standard for information security management systems. It sets stringent guidelines for organizations to identify, manage, and reduce security risks e....

The SCMR Technologist Award recognizes technologists who have made exemplary contributions to the Society and/or field of CMR. Candidates for this award should demonstrate a track record of distinguished service to the Society in the area of technologist education, training, practice development, mentoring, or research. Technologists can be nominated for this award by other SCMR members or the Aw....

Dr Rhodri Davies – UCL and Barts Heart Centre. Artificial intelligence is fuelling a new era of medicine. Dr Rhodri Davies has developed a new AI tool to detect heart disease in MRI images at record speed. This technology will support doctors in their ability to more accurately diagnose and treat patients, while saving precious clinician time. Source: Vote for your favourite BHF-funded rese....

Although a relatively young company, Mycardium’s specialization in advanced AI-enhanced analysis of cardiac images has already brought it to the attention of some of the world’s leading developers of new treatments for cardiac diseases and conditions. Mycardium’s Core Lab Services combine internationally recognized expertise with the enhanced accuracy, precision and consistency, ....

On Friday 10th February, Mycardium AI was delighted to receive the Liverpool City Region 'Official Tech Climber 2023' award, an award that recognises positive representation for the city of Liverpool in the technology sector from innovative and growing organisations. At a packed meeting held at the Love Lane Brewery in Liverpool, Chief Commercial Officer and Co-Founder of Mycardium AI Antony Shimm....

Data security and data protection are both critical to Mycardium, and as a company we are committed to the very highest standards possible. We are pleased to announce completion of the NHS Data Security & Protection Toolkit by Mycardium staff. Mycardium’s regulatory lead, Michael Walker stated: Mycardium is committed to meeting the National Data Guardian’s (NDG) Data Security an....

The BRITISH Study (led by Dr Andrew Flett of University Hospitals Southampton) has recently been awarded £1.8m from the BHF. The study aims to determine whether heart muscle scar predicts high risk in dilated cardiomyopathy and therefore the use of implantable cardioverter defibrillators (ICD). The trial (1252 patients, 35 UK centres) will analyse Cardiac MRI scans and randomize those with s....